February 17, 2025
Image default
Politics

U.S. delays decision on COVID vaccine for children under 5 by at least 2 months

Published by
Reuters

By Ankur Banerjee and Michael Erman (Reuters) – A U.S. decision on Pfizer and BioNTech’s COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data. The FDA had planned to make a decision on the vaccine based on early trial data because of what it had called a great public health need due to the surge in infections caused by the Omicron variant of the coronavirus. The decision was slated for next week with a rollout starting as soon as Feb. 21. On Friday, the agency said it had reviewe…

Read More

Related posts

U.S. House panel eyes interim report by summer 2022 on Jan. 6 attack

The_Proponent

New York elects ex-cop Adams as second ever Black mayor

The_Proponent

White House channels infrastructure funds to snarled ports

The_Proponent

Madeleine Albright, first female US secretary of state, dies at 84

The_Proponent

New York judge vacates convictions of two men for 1965 murder of Malcolm X

The_Proponent

Zelensky expects Russia to storm Kiev during the night

The_Proponent

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.